Kopp Family Office, LLC
In its 13F for Q3 2025 (holdings as of September 30, 2025, filed October 16, 2025), Kopp Family Office, LLC reported 26 stock positions worth $153.6 million. Its top holding was Vanguard Ftse Developed ETF (VEA) at 19.2% of the portfolio, followed by Vanguard Ftse Emerging Marke (VWO, 12.2%) and Invesco S&P 500 Equal Weight (RSP, 9.8%). Compared with Q2 2025, it sold out of 1, added to 3 and reduced 10. The biggest buy was Invesco S&P 500 Equal Weight (RSP, shares +5%) and the biggest sale an exit from Vimeo (VMEO).
- Most Recent 13F
- Q2 2026
- Location
- MINNETONKA, MN
- CIK
- 0001683689
- Portfolio Value
- $153.6M (Q3 2025)
- SEC Filing
- 0000892712-25-000123 ↗ filed Oct 16, 2025
Holdings Value
Holdings 26 stocks · $153.6M
| VEA Vanguard Ftse Developed ETF | 19.21% | 492,575 | $29.5M | Reduce -2.3% |
| VWO Vanguard Ftse Emerging Marke | 12.21% | 346,080 | $18.8M | Reduce -3.5% |
| RSP Invesco S&P 500 Equal Weight | 9.82% | 79,505 | $15.1M | Add +5.4% |
| IJH iShares Core S&P Midcap ETF | 7.83% | 184,293 | $12.0M | Add +6.5% |
| AGG iShares Core U.S. Aggregate | 7.54% | 115,580 | $11.6M | Add +4.7% |
| XMTR Xometry Inc. Class A | 4.79% | 135,207 | $7.4M | Reduce -1.9% |
| FIVN FIVE9 Inc. | 4.71% | 298,870 | $7.2M | No change |
| NTNX Nutanix Inc. Class A | 4.45% | 91,946 | $6.8M | Reduce -1.2% |
| VCEL Vericel Corp. | 3.54% | 172,657 | $5.4M | No change |
| ATEC Alphatec Holdings Inc. | 3.46% | 365,055 | $5.3M | Reduce -1.2% |
| HWKN Hawkins Inc. | 3.40% | 28,627 | $5.2M | Reduce -0.1% |
| WK Workiva Inc. | 3.23% | 57,566 | $5.0M | Reduce -42.9% |
| TEAM Atlassian Corp. Class A | 2.72% | 26,203 | $4.2M | Reduce -0.7% |
| VRDN Viridian Therapeutics Inc. | 2.72% | 193,830 | $4.2M | Reduce -4.6% |
| NEO Neogenomics Inc. | 2.33% | 463,860 | $3.6M | Reduce -43.1% |
| MSFT Microsoft Corp. | 2.27% | 6,724 | $3.5M | No change |
| MANH Manhattan Associates Inc. | 2.26% | 16,941 | $3.5M | No change |
| INSP Inspire Medical Systems Inc. | 1.96% | 40,614 | $3.0M | No change |
| TCMD Tactile Systems Technology I | 1.22% | 135,543 | $1.9M | No change |
| IEFA iShares Core MSCI Eafe ETF | 0.08% | 1,400 | $122K | No change |
| IVV iShares Core S&P 500 ETF | 0.07% | 159 | $106K | No change |
| ISTB iShares Core 1-5 Year Usd Bo | 0.07% | 2,173 | $106K | No change |
| IEMG iShares Core MSCI Emerging | 0.05% | 1,150 | $76K | No change |
| IAGG iShares Intl Aggregate Bond | 0.03% | 839 | $43K | No change |
| IMTB iShares Core 5-10 Year Usd | 0.03% | 911 | $40K | No change |
| IJR iShares Core S&P Small-Cap E | 0.01% | 141 | $17K | No change |
Portfolio Sells Q2 2025 → Q3 2025
| VMEO Vimeo Inc. | Sold out | 0.00% | −1.67 |
| NEO Neogenomics Inc. | Reduce -43.1% | 2.33% | −1.52 |
| WK Workiva Inc. | Reduce -42.9% | 3.23% | −1.24 |
| TEAM Atlassian Corp. Class A | Reduce -0.7% | 2.72% | −0.74 |
| NTNX Nutanix Inc. Class A | Reduce -1.2% | 4.45% | −0.15 |
| VEA Vanguard Ftse Developed ETF | Reduce -2.3% | 19.21% | +0.62 |
| VWO Vanguard Ftse Emerging Marke | Reduce -3.5% | 12.21% | +0.73 |
| HWKN Hawkins Inc. | Reduce -0.1% | 3.40% | +0.77 |
| ATEC Alphatec Holdings Inc. | Reduce -1.2% | 3.46% | +0.80 |
| VRDN Viridian Therapeutics Inc. | Reduce -4.6% | 2.72% | +0.88 |
| XMTR Xometry Inc. Class A | Reduce -1.9% | 4.79% | +1.78 |
Portfolio Buys Q2 2025 → Q3 2025
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 29 | $163.2M | AGG, VEA, RSP, SPY, VWO |
| Q1 2026 | 21 | $145.3M | VEA, AGG, RSP, SPY, VWO |
| Q4 2025 | 21 | $156.7M | VEA, RSP, IJH, VWO, AGG |
| Q3 2025 | 26 | $153.6M | VEA, VWO, RSP, IJH, AGG |
| Q2 2025 | 27 | $154.5M | VEA, VWO, RSP, AGG, IJH |
| Q1 2025 | 28 | $144.7M | VEA, VWO, AGG, FIVN, WK |
| Q4 2024 | 21 | $157.8M | VEA, VWO, VCEL, NEO, FIVN |
| Q3 2024 | 22 | $157.0M | VEA, VWO, VCEL, NEO, FIVN |
| Q2 2024 | 21 | $161.2M | VEA, IWM, VCEL, VWO, FIVN |
| Q1 2024 | 21 | $175.1M | VEA, IWM, VCEL, VWO, FIVN |